tradingkey.logo

Intuitive Surgical Inc

ISRG
534.280USD
+4.260+0.80%
Close 10/31, 16:00ETQuotes delayed by 15 min
189.62BMarket Cap
69.03P/E TTM

Intuitive Surgical Inc

534.280
+4.260+0.80%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Intuitive Surgical Inc

Currency: USD Updated: 2025-10-31

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Intuitive Surgical Inc's Score

Industry at a Glance

Industry Ranking
11 / 210
Overall Ranking
64 / 4618
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 35 analysts
Buy
Current Rating
598.118
Target Price
+12.85%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Intuitive Surgical Inc Highlights

StrengthsRisks
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 34.23% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 8.35B.
Undervalued
The company’s latest PE is 69.47, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 317.45M shares, decreasing 1.33% quarter-over-quarter.
Held by Manning & Napier Group, LLC
Star Investor Manning & Napier Group, LLC holds 240.49K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-31

The company's current financial score is 9.28, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 2.51B, representing a year-over-year increase of 22.91%, while its net profit experienced a year-over-year increase of 24.65%.

Score

Industry at a Glance

Previous score
9.28
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

8.56

Operational Efficiency

10.00

Growth Potential

10.00

Shareholder Returns

7.84

Intuitive Surgical Inc's Company Valuation

Currency: USD Updated: 2025-10-31

The company’s current valuation score is 5.43, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 69.47, which is 34.39% below the recent high of 93.36 and 19.59% above the recent low of 55.86.

Score

Industry at a Glance

Previous score
5.43
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 11/210
No Data

Earnings Forecast

Currency: USD Updated: 2025-10-31

The company’s current earnings forecast score is 7.82, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Intuitive Surgical Inc is 601.50, with a high of 700.00 and a low of 440.00.

Score

Industry at a Glance

Previous score
7.82
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 35 analysts
Buy
Current Rating
598.118
Target Price
+12.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

89
Total
4
Median
7
Average
Company name
Ratings
Analysts
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
30
Danaher Corp
DHR
25
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-31

The company’s current price momentum score is 9.57, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 581.91 and the support level at 457.24, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.51
Change
0.06

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
14.423
Buy
RSI(14)
68.765
Neutral
STOCH(KDJ)(9,3,3)
82.751
Neutral
ATR(14)
17.796
High Vlolatility
CCI(14)
48.161
Neutral
Williams %R
14.615
Overbought
TRIX(12,20)
0.861
Sell
StochRSI(14)
9.098
Oversold
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
539.706
Sell
MA10
524.458
Buy
MA20
482.257
Buy
MA50
464.381
Buy
MA100
484.591
Buy
MA200
512.029
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-31

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 88.55%, representing a quarter-over-quarter decrease of 0.92%. The largest institutional shareholder is The Vanguard, holding a total of 33.18M shares, representing 9.36% of shares outstanding, with 4.11% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
33.18M
+2.05%
BlackRock Institutional Trust Company, N.A.
19.09M
+0.91%
State Street Investment Management (US)
15.55M
+1.19%
T. Rowe Price Associates, Inc.
Star Investors
12.88M
-2.82%
Fidelity Management & Research Company LLC
8.43M
-10.67%
Geode Capital Management, L.L.C.
8.19M
+1.36%
Capital World Investors
7.61M
+1.25%
Invesco Capital Management (QQQ Trust)
7.34M
-0.35%
JP Morgan Asset Management
4.92M
-11.33%
Norges Bank Investment Management (NBIM)
4.73M
+2.76%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-31

The company’s current risk assessment score is 8.60, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 1.63. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
8.60
Change
0
Beta vs S&P 500 index
1.63
VaR
+3.17%
240-Day Maximum Drawdown
+29.63%
240-Day Volatility
+37.66%

Return

Best Daily Return
60 days
+13.89%
120 days
+13.89%
5 years
+14.27%
Worst Daily Return
60 days
-5.95%
120 days
-5.95%
5 years
-14.34%
Sharpe Ratio
60 days
+1.44
120 days
+0.13
5 years
+0.60

Risk Assessment

Maximum Drawdown
240 days
+29.63%
3 years
+29.63%
5 years
+49.90%
Return-to-Drawdown Ratio
240 days
-0.02
3 years
+1.15
5 years
+0.46
Skewness
240 days
+1.45
3 years
+1.34
5 years
+0.44

Volatility

Realised Volatility
240 days
+37.66%
5 years
+33.13%
Standardised True Range
240 days
+2.69%
5 years
+1.74%
Downside Risk-Adjusted Return
120 days
+22.01%
240 days
+22.01%
Maximum Daily Upside Volatility
60 days
+39.97%
Maximum Daily Downside Volatility
60 days
+35.99%

Liquidity

Average Turnover Rate
60 days
+0.54%
120 days
+0.57%
5 years
--
Turnover Deviation
20 days
+10.81%
60 days
+14.06%
120 days
+19.15%

Peer Comparison

Healthcare Equipment & Supplies
Intuitive Surgical Inc
Intuitive Surgical Inc
ISRG
8.17 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
Boston Scientific Corp
BSX
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hologic Inc
Hologic Inc
HOLX
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI